 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$5.67 |
$5.67 |
$5.12 |
$5.36 |
96.00K | | 04/16/2024 |
$5.30 |
$5.30 |
$4.68 |
$4.76 |
37.00K | | 04/17/2024 |
$4.74 |
$5.43 |
$4.70 |
$5.32 |
34.90K | | 04/18/2024 |
$5.24 |
$5.53 |
$5.22 |
$5.44 |
21.30K | | 04/19/2024 |
$5.41 |
$5.53 |
$5.26 |
$5.27 |
11.30K |
|
|
| Lipocine is clinical-stage biopharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products focusing on neuroendocrine and metabolic disorders. Co. has a license agreement for the development and commercialization its product candidate, TLANDO®, an oral testosterone replacement therapy comprised of testosterone undecanoate. Co.'s additional pipeline candidates, LPCN 1148 comprising a prodrug of testosterone, testosterone laurate, for the management of decompensated cirrhosis. Co. is conducting a Phase 2 POC study in male cirrhotic subjects to evaluate the therapeutic potential of LPCN 1148 for the management of sarcopenia. | |
|
Lipocine (LPCN) has the following price history information. Looking back at LPCN historical stock prices for the last five trading days, on April 15, 2024, LPCN opened at $5.67, traded as high as $5.67 and as low as $5.12, and closed at $5.36. Trading volume was a total of 96.00K shares. On April 16, 2024, LPCN opened at $5.30, traded as high as $5.30 and as low as $4.68, and closed at $4.76. Trading volume was a total of 37.00K shares. On April 17, 2024, LPCN opened at $4.74, traded as high as $5.43 and as low as $4.70, and closed at $5.32. Trading volume was a total of 34.90K shares. On April 18, 2024, LPCN opened at $5.24, traded as high as $5.53 and as low as $5.22, and closed at $5.44. Trading volume was a total of 21.30K shares. On April 19, 2024, LPCN opened at $5.41, traded as high as $5.53 and as low as $5.26, and closed at $5.27. Trading volume was a total of 11.30K shares.
LPCN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lipocine shares, starting with a $10,000 purchase of LPCN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$130.73 |
|
| End price/share: |
$5.27 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-95.97% |
|
| Average Annual Total Return: |
-27.47% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$402.88 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/15/2024 | $5.36 | | 04/16/2024 | $4.76 | | 04/17/2024 | $5.32 | | 04/18/2024 | $5.44 | | 04/19/2024 | $5.27 |
|
|
Free LPCN Email Alerts:
